31 Dicembre 2022 In Notizie By Cinzia Sacchetti
Il 2022 termina con una bella notizia per tutti i giovani pazienti affetti da aploinsufficienza del gene SHOX in terapia con GH. Il 29 dicembre è uscita la Gazzetta Ufficiale con la determina AIFA che consente la prosecuzione del trattamento con somatropine analoghe.
Scarica i documenti:
GU 303_29dic2022_somatropina off label
Inserimento somatropina in elenco del 29-12-2022
| Cookie | Durata | Descrizione |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
